3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Head and Neck Neoplasms
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Laryngeal Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Warts
1
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Retinoblastoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papillomavirus Infections
1
Papilloma
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Interventions
Docetaxel
277
Prednisone
236
enzalutamide
175
Leuprolide
172
Radiotherapy
164
Abiraterone Acetate
153
Magnetic Resonance Spectroscopy
147
bicalutamide
137
Goserelin
134
Androgen Antagonists
111
Radiosurgery
101
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
100
apalutamide
78
abiraterone
75
gallium 68 PSMA-11
74
Specimen Handling
67
Gonadotropin-Releasing Hormone
58
darolutamide
56
Radiation
56
Triptorelin Pamoate
53
cabazitaxel
49
Zoledronic Acid
49
pembrolizumab
48
Radiotherapy, Intensity-Modulated
47
Flutamide
47
Brachytherapy
47
luprolide acetate gel depot
46
Standard of Care
45
Carboplatin
44
Estramustine
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Neoplasms
×
Laser Therapy
×
Clear all
NCT02357121
2020-09-21
FLA
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1
Completed
11 enrolled